You are here
Home > News > The Pink Pill: “Female Viagra” Backed By FDA Panel

The Pink Pill: “Female Viagra” Backed By FDA Panel

 

By a vote of 18-6, the advisory panel for the Food and Drug Administration has recommended approval of flibanserin, a drug used to treat sexual dysfunction in women, the New York Times reports.

If approved by the FDA, the pink pill will be used to assist premenopausal women who suffer from low sex drive not caused by disease or relationship problems. While the FDA frequently accepts recommendations offered by the panel, they are not required to do so. Women’s organizations behind the Even The Score campaign are in favor of the board’s decision, as they have accused the FDA of gender bias because they approved Viagra but rejected its female counterpart in the past.

As with many drugs, there are several potential side effects including low-blood pressure, fainting, nausea, dizziness, and drowsiness. The panel’s approval of the drug included conditions like labels that inform consumers of the associated risks. Of course, not everyone is in favor of drug being released to the market. The panel’s decision regarding the drug is a huge step, as it was rejected by the panel twice before because they felt that the risks associated with taking the pill outweighed the benefits.

“To approve this drug would set the worst kind of precedent: that companies that spend enough money can force the FDA to approve useless and dangerous drugs,” Dr. Adriane Fugh-Berman of Georgetown University told CBS News.

The FDA will make an official decision regarding flibanserin’s approval by August 18, 2015.

Related Posts Plugin for WordPress, Blogger...

One thought on “The Pink Pill: “Female Viagra” Backed By FDA Panel

  1. Even if the drug has the backing of FDA, the responsibility still lies with you and your doctor.I believe that will be hyper reactive to the drug whereas it will have no adverse effect on others. Only use drugs that are healthy for you

Leave a Reply

Top